Description
Carbimazole Tablets
Carbimazole Tablets BP / IP / USP (5 mg / 10 mg)
Healthy Life Pharma Private Limited, alongside our specialized global export division Healthy Inc, is a premier manufacturer, supplier, and exporter of advanced endocrinology, metabolic health, and internal medicine therapeutics. We manufacture ultra-high-purity, kinetically stable Carbimazole Tablets in our WHO–GMP certified, high-precision solid dosage manufacturing facilities. This foundational “Antithyroid Agent” serves as a critical bulk export to endocrinology clinics, state hospital networks, international B2B wholesale marketplaces, and government tender procurement pipelines across Europe, the CIS region, Africa, and SE Asia.
Product Overview
This formulation operates as a “Hormonal Synthesis Inhibitor.” It ensures patient safety by chemically shutting down the overproduction of thyroid hormones at the cellular level, effectively treating states of metabolic hyperactivity.
Mechanism 1 (Active Metabolite Conversion): Carbimazole is a prodrug. Upon oral ingestion, it physically undergoes rapid and complete chemical conversion in the body to its active form, Methimazole.
Mechanism 2 (Thyroid Peroxidase Inhibition): The active metabolite chemically binds to and physically inhibits the enzyme Thyroid Peroxidase (TPO). This enzyme is responsible for the iodination of tyrosine residues in thyroglobulin.
Mechanism 3 (Hormone Synthesis Blockade): By physically blocking TPO, it chemically prevents the coupling of monoiodotyrosine (MIT) and diiodotyrosine (DIT). This completely halts the physical production of Thyroxine ($T_{4}$) and Triiodothyronine ($T_{3}$), gradually restoring a “Euthyroid” (metabolically normal) state.
Product Composition & Available Strengths
We manufacture Carbimazole in exact, internationally recognized strengths to facilitate precise dosage titration based on periodic patient blood chemistry.
| Active Ingredient | Standard Strengths | Primary Clinical Target |
| Carbimazole BP/IP/USP | 5 mg | Maintenance Titration: For long-term control once stable thyroid levels are chemically achieved. |
| Carbimazole BP/IP/USP | 10 mg | Initial Suppression: High-dose intervention to rapidly bring down severely elevated $T_{3}$/$T_{4}$ levels. |
Technical & Logistics Specifications
HS Code: 3004.39.12 (Medicaments containing hormones / Antithyroid preparations)
CAS Number: 22232-54-8 (Carbimazole)
Dosage Form: Oral Tablet (Uncoated or Film-Coated)
Packaging: 10 or 15 Tablets per Blister in high-barrier Alu-Alu (Cold-Form Foil) or secure blister packs. Our premium packaging matrices guarantee a 36-month shelf life in Zone IVb tropical export environments.
Manufacturing Authority & Compliance
Dedicated Hormonal Line Isolation: Carbimazole is a highly potent active hormonal modifier. Our manufacturing process utilizes Dedicated Solid Dosage Lines with Isolated Air-Handling Systems (HVAC), physically ensuring absolute zero cross-contamination with other drug classes—a vital parameter for international B2B validation.
Micro-Dose Weight and Content Uniformity: Because thyroid regulation is physically sensitive to minor dosing shifts, we employ Automated High-Speed Compression Matrices, physically guaranteeing that every single tablet contains an identical chemical dose down to the micro-gram.
Kinetic Bioavailability Validation: Every production batch physically undergoes Comparative Dissolution Profiling, chemically ensuring that our generic tablets match the exact bioavailability curve of global innovator standards (such as Neo-Mercazole or Bimazole).
Primary Indications
Endocrinology: Definitive medical management of Hyperthyroidism and Grave’s Disease.
Pre-Surgical Stabilization: Chemical preparation of hyperthyroid patients prior to undergoing a physical Thyroidectomy (surgical thyroid removal).
Nuclear Medicine Adjuvant: Symptomatic control before, during, and after Radioactive Iodine (I-131) therapeutic protocols.
Usage Instructions
Administration: Swallow the tablet physically whole with a glass of water. It can be taken consistently with or without food.
The Titration Mandate: Dosing must be chemically monitored and adjusted by an endocrinology specialist based on sequential Thyroid Function Tests (TFTs) tracking blood serum $TSH$, Free $T_{4}$, and Free $T_{3}$.
Agranulocytosis Awareness: Patients must be explicitly instructed to physically report any sudden fever, painful sore throat, or mouth ulcers immediately, as these may chemically indicate a severe but rare bone marrow suppression.
Safety Warning: POTENT ENDOCRINE MODIFIER. For Professional Supervision Only. Agranulocytosis Risk: May physically cause a dangerous drop in white blood cell count; monitor hematology profiles chemically if infection signs occur. Pregnancy Note: Crosses the placental barrier; use the lowest effective dose under strict clinical scrutiny to prevent fetal thyroid dysfunction. Contraindication: Do not use in patients with severe pre-existing blood dyscrasias, acute hepatic failure, or known hypersensitivity to Carbimazole or Methimazole derivatives.
Global Export & Contract Manufacturing (CDMO Services)
Healthy Life Pharma Private Limited provides complete, fully validated Third-Party Contract Manufacturing (CDMO) for generic Carbimazole Tablets. Whether you are fulfilling a National Health Service Tender in the CIS, stocking an endocrine hospital distribution chain in Africa, or listing products on an international B2B Pharma Marketplace in SE Asia or Europe, we prepare all required regulatory dossiers (COA, COPP, Stability Data, CTD Dossiers) for rapid global registration.
Commercial & Bulk Inquiries:
WhatsApp/Call: +91 7710003340
Email: info@healthyinc.co.in
